![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication July 5, 2007.
Revised October 23, 2007.
Accepted for publication October 23, 2007.
P2X7 receptors are distinct from other ATP-gated P2X receptors in that they are potently inhibited by submicromolar concentrations of zinc and copper. The molecular basis for the strong functional inhibition by zinc and copper at this purinergic ionotropic receptor is controversial. We hypothesized that it involves a direct interaction of zinc and copper with residues in the ectodomain of the P2X7 receptor. There are 14 potential metal interacting residues conserved in the ectodomain of all mammalian P2X7 receptors, none of which are homologous to previously identified sites in other P2X receptors shown to be important for functional potentiation by zinc. We introduced alanine substitutions into each of these residues, expressed wild type and mutated receptors in HEK293 cells and recorded resulting ATP and BzATP-evoked membrane currents. Agonist concentration-response curves were similar for all the twelve functional mutant receptors. Alanine substitution at His62 or Asp197 strongly attenuated both zinc and copper inhibition, and the double mutant [H62A/D197A] mutant receptor was virtually insensitive to inhibition by zinc or copper. Thus, we conclude that zinc and copper inhibition is due to a direct interaction of these divalent cations with ectodomain residues of the P2X7 receptor, primarily involving combined interaction with His62 and Asp197 residues.
Key words:
Purinergic, Purinergic, Structure determinations, Func. analysis receptor/ion channel mutants, Mutagenesis/Chimeric approaches